Recruiting Clinical Trials

Displaying 1 - 10 of 237 result(s)
Study Title Condition Phase Location
A Phase Ib, Multi-arm, Open-label, Study of HDM201 in Combination With MBG453 or Venetoclax in Adult Subjects With Acute Myeloid Leukemia (AML) or High-risk Myelodysplastic Syndrome (MDS) Acute Myeloid Leukemia (AML), High-risk Myelodysplastic Syndrome (MDS) Phase 1
  • Country: 
    United States
  • Country: 
    Germany
  • Country: 
    Singapore
  • Country: 
A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of Dabrafenib Plus Trametinib in Previously Treated Patients With Locally Advanced or Metastatic, Radio-active Iodine Refractory BRAFV600E Mutation-pos ... Differentiated Thyroid Cancer Phase 3
  • Country: 
    Argentina
  • Country: 
    Brazil
  • Country: 
    Canada
  • Country: 
A Phase Ib Dose Finding Study Assessing Safety and Activity of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Extensive Stage Small Cell Lung Cancer (ES-SCLC) in Combination With Carboplatin, Etoposide and Tislelizumab in Induction and With Tislelizumab in M ... Extensive Stage Small Cell Lung Cancer Phase 1
  • Country: 
    France
  • Country: 
    Spain
A Randomized, Double-blind, Phase III Study, Comparing NIS793 in Combination With Gemcitabine and Nab-paclitaxel Versus (vs.) Placebo Combined With Gemcitabine and Nab-paclitaxel for First Line Treatment of Metastatic Pancreatic Ductal Adenocarcinoma ... Metastatic Pancreatic Ductal Adenocarcinoma Phase 3
  • Country: 
    United States
  • Country: 
    Australia
  • Country: 
    Belgium
  • Country: 
EPIK-O: A Phase III, Multi-center, Randomized (1:1), Open-label, Active-controlled, Study to Assess the Efficacy and Safety of Alpelisib (BYL719) in Combination With Olaparib as Compared to Single Agent Cytotoxic Chemotherapy, in Participants With no ... Ovarian Cancer Phase 3
  • Country: 
    United States
  • Country: 
    Argentina
  • Country: 
    Australia
  • Country: 
A Randomized, Participant- and Investigator-blinded, Placebo-controlled Study to Investigate Efficacy, Safety, and Tolerability of LTP001 in Participants With Pulmonary Arterial Hypertension Pulmonary Arterial Hypertension Phase 2
  • Country: 
    Germany
  • Country: 
    Netherlands
  • Country: 
    Poland
  • Country: 
A Phase II Open-label, 2-Part, Multi-center Study of BYL719 (Alpelisib) in Combination With Fulvestrant for Men and Postmenopausal Women With PIK3CA Mutation Hormone Receptor (HR) Positive, HER2-negative, Advanced Breast Cancer Which Progressed on or ... Advanced Breast Cancer Phase 2
  • Country: 
    Japan
Phase III Study for Evaluation of the Diagnostic Performance of [18F]CTT1057 PET Imaging in Patients With Prostate Cancer With Rising PSA Levels [Biochemical Recurrence (BCR)] Prostatic Neoplasms, Prostate Cancer, Recurrence Phase 3
  • Country: 
    France
  • Country: 
    Spain
  • Country: 
    Switzerland
Phase I, Open-label, Multicenter Study to Evaluate the Imaging Performance, Safety, Biodistribution and Dosimetry of [68Ga]-FF58 in Adult Patients With Selected Solid Tumors Expected to Overexpress αvβ3 and αvβ5 Integrins. Glioblastoma Multiforme, Brain Neoplasms, Gastroesophageal Adenocarcinoma, Pancreatic Ductal Adenocarcinoma Phase 1
  • Country: 
    France
Special Drug Use Observational Study With Beovu Kit for Intravitreal Injection (DME, CRTH258B1401) Diabetic Macular Edema Not Given
  • Country: 
    Japan